Steve Bates OBE, Chief Executive of the BIA said: “It’s fantastic to see the NHS and Vertex strike a lightning quick deal to enable NHS cystic fibrosis patients to access this important breakthrough therapy.
New figures published today (Monday 22 June 2020) by the UK BioIndustry Association (BIA) and Clarivate reveal that the UK biotech sector raised £585million from March to May 2020. A total of £894m has now been raised from all sources in the first half of 2020, surpassing the £831m raised in the same period in 2018, which was a record-breaking year.
A new support fund for innovative firms struggling to access equity finance during the COVID-19 disruption has opened for applications today (20 May). The Future Fund, run by the British Business Bank, will provide convertible loans of between £125,000 and £5m to businesses if they can also secure matched funding from third-party investors.
Commenting on the day of the 100,000 testing target, Steve Bates OBE, Chief Executive of the BIA said: “It’s gratifying to see the Government recognises the major role the UK life sciences industry has played in the collaborative, speedy and innovative national effort to increase testing capability.
Steve Bates OBE, Chief Executive of the BIA said: “UK life sciences companies already working on key elements of manufacturing, through the BIA taskforce, look forward to working with AstraZeneca on the vital development and scale up of the Jenner COVID-19 vaccine.